GeoVax Labs, Inc. (GOVX) Receives $3.6 Million U.S. Government Grant
GeoVax Labs, Inc. is a biopharmaceutical company developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections. Its goal is to develop an AIDS vaccine for use globally. The company announced today that it received a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development Grant supporting GeoVax's HIV/AIDS vaccine program. Only meritorious HIV/AIDS prevention vaccine candidates are considered to receive this award. GeoVax first received this government award back in 2007. The most recent award represents the fifth year it has received an award, bringing the total awarded to date to $19.6 million. GeoVax…